316 related articles for article (PubMed ID: 15537895)
1. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.
Cressant A; Desmaris N; Verot L; Bréjot T; Froissart R; Vanier MT; Maire I; Heard JM
J Neurosci; 2004 Nov; 24(45):10229-39. PubMed ID: 15537895
[TBL] [Abstract][Full Text] [Related]
2. Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery.
Fu H; Samulski RJ; McCown TJ; Picornell YJ; Fletcher D; Muenzer J
Mol Ther; 2002 Jan; 5(1):42-9. PubMed ID: 11786044
[TBL] [Abstract][Full Text] [Related]
3. Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery.
Fu H; DiRosario J; Kang L; Muenzer J; McCarty DM
J Gene Med; 2010 Jul; 12(7):624-33. PubMed ID: 20603889
[TBL] [Abstract][Full Text] [Related]
4. Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice.
Heldermon CD; Qin EY; Ohlemiller KK; Herzog ED; Brown JR; Vogler C; Hou W; Orrock JL; Crawford BE; Sands MS
Gene Ther; 2013 Sep; 20(9):913-21. PubMed ID: 23535899
[TBL] [Abstract][Full Text] [Related]
5. Treatment of the mouse model of mucopolysaccharidosis type IIIB with lentiviral-NAGLU vector.
Di Natale P; Di Domenico C; Gargiulo N; Castaldo S; Gonzalez Y Reyero E; Mithbaokar P; De Felice M; Follenzi A; Naldini L; Villani GR
Biochem J; 2005 Jun; 388(Pt 2):639-46. PubMed ID: 15649123
[TBL] [Abstract][Full Text] [Related]
6. Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial.
Tardieu M; Zérah M; Gougeon ML; Ausseil J; de Bournonville S; Husson B; Zafeiriou D; Parenti G; Bourget P; Poirier B; Furlan V; Artaud C; Baugnon T; Roujeau T; Crystal RG; Meyer C; Deiva K; Heard JM
Lancet Neurol; 2017 Sep; 16(9):712-720. PubMed ID: 28713035
[TBL] [Abstract][Full Text] [Related]
7. Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB.
Zheng Y; Ryazantsev S; Ohmi K; Zhao HZ; Rozengurt N; Kohn DB; Neufeld EF
Mol Genet Metab; 2004 Aug; 82(4):286-95. PubMed ID: 15308126
[TBL] [Abstract][Full Text] [Related]
8. Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.
Holley RJ; Ellison SM; Fil D; O'Leary C; McDermott J; Senthivel N; Langford-Smith AWW; Wilkinson FL; D'Souza Z; Parker H; Liao A; Rowlston S; Gleitz HFE; Kan SH; Dickson PI; Bigger BW
Brain; 2018 Jan; 141(1):99-116. PubMed ID: 29186350
[TBL] [Abstract][Full Text] [Related]
9. Intracranial gene delivery of LV-NAGLU vector corrects neuropathology in murine MPS IIIB.
Di Domenico C; Villani GR; Di Napoli D; Nusco E; Calì G; Nitsch L; Di Natale P
Am J Med Genet A; 2009 Jun; 149A(6):1209-18. PubMed ID: 19449420
[TBL] [Abstract][Full Text] [Related]
10. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase.
Li HH; Yu WH; Rozengurt N; Zhao HZ; Lyons KM; Anagnostaras S; Fanselow MS; Suzuki K; Vanier MT; Neufeld EF
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14505-10. PubMed ID: 10588735
[TBL] [Abstract][Full Text] [Related]
11. Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice.
Fu H; Kang L; Jennings JS; Moy SS; Perez A; Dirosario J; McCarty DM; Muenzer J
Gene Ther; 2007 Jul; 14(14):1065-77. PubMed ID: 17460717
[TBL] [Abstract][Full Text] [Related]
12. Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome.
Kan SH; Elsharkawi I; Le SQ; Prill H; Mangini L; Cooper JD; Lawrence R; Sands MS; Crawford BE; Dickson PI
Mol Genet Metab; 2021 Jun; 133(2):185-192. PubMed ID: 33839004
[TBL] [Abstract][Full Text] [Related]
13. Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy.
Ribera A; Haurigot V; Garcia M; Marcó S; Motas S; Villacampa P; Maggioni L; León X; Molas M; Sánchez V; Muñoz S; Leborgne C; Moll X; Pumarola M; Mingozzi F; Ruberte J; Añor S; Bosch F
Hum Mol Genet; 2015 Apr; 24(7):2078-95. PubMed ID: 25524704
[TBL] [Abstract][Full Text] [Related]
14. Repeated administrations of human umbilical cord blood cells improve disease outcomes in a mouse model of Sanfilippo syndrome type III B.
Willing AE; Garbuzova-Davis SN; Zayko O; Derasari HM; Rawls AE; James CR; Mervis RF; Sanberg CD; Kuzmin-Nichols N; Sanberg PR
Cell Transplant; 2014; 23(12):1613-30. PubMed ID: 25565636
[TBL] [Abstract][Full Text] [Related]
15. Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome.
Gougeon ML; Poirier-Beaudouin B; Ausseil J; Zérah M; Artaud C; Heard JM; Deiva K; Tardieu M
Front Immunol; 2021; 12():655478. PubMed ID: 34040605
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B.
Garbuzova-Davis S; Klasko SK; Sanberg PR
J Comp Neurol; 2009 Jul; 515(1):93-101. PubMed ID: 19399896
[TBL] [Abstract][Full Text] [Related]
17. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency.
Lotfi P; Tse DY; Di Ronza A; Seymour ML; Martano G; Cooper JD; Pereira FA; Passafaro M; Wu SM; Sardiello M
Autophagy; 2018; 14(8):1419-1434. PubMed ID: 29916295
[TBL] [Abstract][Full Text] [Related]
18. BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis.
Yogalingam G; Luu AR; Prill H; Lo MJ; Yip B; Holtzinger J; Christianson T; Aoyagi-Scharber M; Lawrence R; Crawford BE; LeBowitz JH
PLoS One; 2019; 14(1):e0207836. PubMed ID: 30657762
[TBL] [Abstract][Full Text] [Related]
19. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.
Gografe SI; Garbuzova-Davis S; Willing AE; Haas K; Chamizo W; Sanberg PR
Comp Med; 2003 Dec; 53(6):622-32. PubMed ID: 14727810
[TBL] [Abstract][Full Text] [Related]
20. Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery.
Fu H; Dirosario J; Killedar S; Zaraspe K; McCarty DM
Mol Ther; 2011 Jun; 19(6):1025-33. PubMed ID: 21386820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
